Hormone Health for Women in Madison: Starting With the Right Tests

By Kyle Kingsley, MD
Medical Director, LiteWell

Estimated Reading Time: 7 minutes

Table of Contents

1. Why Hormone Testing Matters for Women
2. The Hormones That Matter Most
3. Signs Your Hormones May Be Off
4. What “Starting With the Right Tests” Actually Means
5. What the Research Tells Us About Hormone Optimization
6. Myths vs. Facts About Women’s Hormone Testing
7. LiteWell’s Clinical Approach
8. Frequently Asked Questions

Why Hormone Testing Matters for Women

Women’s hormonal health is among the most underserved areas in conventional medicine. Despite decades of research documenting the central role hormones play in nearly every aspect of female physiology, routine care rarely includes the kind of thorough hormonal workup that could explain — and potentially resolve — a wide range of chronic complaints.

The problem begins with how “normal” is defined. Reference ranges on standard lab reports are typically calculated from broad population samples. A woman whose estradiol is at the bottom of the reference range may technically be “normal” by that standard, while experiencing significant symptoms that impair her quality of life. The reference range tells you what is statistically common — it doesn’t tell you what is optimal for that patient.

There is also the issue of what gets tested in the first place. A standard thyroid panel may only include TSH, missing the full picture of thyroid function that free T3, free T4, and thyroid antibodies would provide. Routine bloodwork rarely captures sex hormones at all unless a specific concern is flagged. And adrenal hormones — particularly cortisol patterns across the day — are almost never evaluated in a typical annual physical.

For women in Madison and the surrounding area who have felt dismissed or whose concerns have been attributed to stress, aging, or mood disorders, this matters enormously. Many are experiencing real physiologic changes that have a measurable basis — and that basis begins with comprehensive, contextualized hormone testing.

Proper evaluation doesn’t just identify deficiencies. It reveals patterns — the interplay between hormones that explains why fatigue, weight gain, sleep disruption, and cognitive changes so often cluster together. Understanding those patterns is the foundation of effective care.

The Hormones That Matter Most

A thorough evaluation for women includes multiple hormone systems, not just reproductive hormones. Each plays a distinct and important role in health, and each can contribute to symptoms when it falls out of optimal range.

Estrogen is the hormone most people associate with women’s health, and for good reason. It influences bone density, cardiovascular function, skin integrity, vaginal health, mood regulation, and cognitive function. Estrogen doesn’t disappear at menopause — it fluctuates significantly during perimenopause and declines to a lower baseline after the final menstrual period. Even small shifts in estrogen during perimenopause can produce noticeable symptoms.

Progesterone works in balance with estrogen throughout the reproductive years. It plays a key role in sleep quality, anxiety regulation, and uterine health. Low progesterone — or an imbalance between progesterone and estrogen sometimes called estrogen dominance — may contribute to irregular cycles, PMS symptoms, poor sleep, and mood instability.

Testosterone is present in women at much lower levels than in men, but it is not negligible. It contributes to libido, energy, lean muscle mass, and sense of well-being. Testosterone levels in women decline with age, and low levels may contribute to fatigue, reduced motivation, and sexual health concerns that are often attributed to other causes.

Thyroid hormones — including TSH, free T3, and free T4 — regulate metabolism throughout the body. Subclinical hypothyroidism is relatively common in women and can mimic or overlap with many symptoms of hormonal imbalance: fatigue, weight gain, cold intolerance, brain fog, and mood changes. A full thyroid panel is essential to any comprehensive hormone evaluation.

Cortisol, produced by the adrenal glands in response to stress, has a profound effect on every other hormone in the body. Chronically elevated cortisol can suppress sex hormone production, disrupt thyroid function, impair sleep, and promote central weight gain. Evaluating cortisol patterns — and understanding how stress physiology may be affecting the broader hormone system — is a critical but often overlooked component of women’s hormone health.

Signs Your Hormones May Be Off

Energy and Sleep Changes

Persistent fatigue that doesn’t respond to rest is one of the most common complaints among women with hormonal imbalances. This may manifest as difficulty getting out of bed in the morning, an energy crash in the afternoon, or an inability to sustain the stamina that once came naturally.

Sleep disruption is closely tied to hormonal shifts. Declining progesterone may reduce sleep quality. Cortisol dysregulation can cause early morning awakening or difficulty falling asleep. Night sweats — a hallmark of perimenopause and menopause — frequently fragment sleep in ways that accumulate significant sleep debt over time.

• Waking frequently during the night or in the early hours
• Unrefreshing sleep despite adequate hours
• Night sweats or hot flashes disrupting rest
• Daytime fatigue that coffee doesn’t resolve
• Afternoon energy crashes that impair function

Mood and Cognitive Shifts

The brain is highly sensitive to hormonal changes. Estrogen and progesterone both have neuroactive properties — they influence neurotransmitter systems including serotonin, dopamine, and GABA. Fluctuations in these hormones can produce mood instability, increased anxiety, irritability, and a general sense of emotional reactivity that may feel out of proportion to circumstances.

Cognitive changes — sometimes called “brain fog” — are reported by many women during perimenopause and menopause. This may include difficulty with word retrieval, reduced concentration, and a sense that thinking feels slower or less sharp than before. Research supports a neurological basis for these changes, linked in part to estrogen’s role in brain metabolism and blood flow.

• Increased anxiety or a sense of dread without a clear cause
• Mood swings that feel hormonally driven
• Difficulty concentrating or “foggy” thinking
• Word-finding difficulty or memory lapses
• Reduced emotional resilience or increased reactivity

Weight and Metabolism Changes

Many women experience shifts in body composition during perimenopause and menopause that persist despite no changes in diet or activity. Fat redistribution — particularly increased accumulation in the abdominal area — is well-documented as a consequence of declining estrogen and shifting cortisol patterns. Metabolism slows, insulin sensitivity may decrease, and lean muscle mass is harder to maintain.

Thyroid dysfunction, which is common in women over 40, can compound these changes significantly. An underactive thyroid slows metabolism directly and may make weight management feel impossible despite appropriate effort.

• Unexplained weight gain, particularly around the midsection
• Difficulty losing weight despite diet and exercise
• Changes in body composition — more fat, less muscle
• Increased bloating or fluid retention
• Feeling cold when others are comfortable

Sexual Health and Comfort

Declining estrogen affects vaginal tissue directly — a condition known as genitourinary syndrome of menopause (GSM) can cause vaginal dryness, discomfort with intercourse, increased urinary urgency, and recurrent urinary tract infections. These symptoms are progressive when untreated and significantly affect quality of life, yet many women are not aware that effective, evidence-based treatments are available.

Low testosterone may reduce libido and the sense of sexual interest or responsiveness. Taken together, these changes can affect intimate relationships and a woman’s sense of her own vitality and well-being.

• Reduced libido or sexual interest
• Vaginal dryness or discomfort during intercourse
• Increased urinary urgency or frequency
• Recurrent urinary tract infections
• Reduced arousal or difficulty with orgasm

What “Starting With the Right Tests” Actually Means

The phrase “starting with the right tests” is not just about running more labs. It is about running the right labs, at the right time, and interpreting them in the context of a patient’s full clinical picture.

A comprehensive hormone panel for women typically includes estradiol, progesterone, total and free testosterone, DHEA-S, sex hormone binding globulin (SHBG), a full thyroid panel (TSH, free T3, free T4, and thyroid antibodies), and cortisol. Depending on symptoms and history, a complete metabolic panel, fasting insulin, and markers of inflammation may also be warranted.

Timing matters — particularly for premenopausal and perimenopausal women. Estrogen and progesterone fluctuate significantly across the menstrual cycle. Testing on the wrong day can produce results that appear normal when they are not, or results that appear abnormal when the levels are simply reflecting a normal phase of the cycle. LiteWell physicians guide patients on when to test for the most meaningful results.

At-home saliva testing and finger-prick kits have become widely marketed to women interested in hormone health. While these tools have some utility, they have important limitations. Saliva hormone levels reflect only a fraction of circulating hormones and can be significantly affected by hydration, oral health, and technique. They are not suitable as the sole basis for clinical decisions. Comprehensive serum testing, interpreted by a physician who understands both the data and the patient, provides a far more reliable picture.

The goal is not to find a single number that explains everything. It is to build a complete picture — one that accounts for symptoms, history, current medications, lifestyle factors, and the full hormonal context — and to use that picture as the foundation for individualized care.

What the Research Tells Us About Hormone Optimization

The evidence base for women’s hormone health has grown substantially over the past two decades, particularly in the years since the Women’s Health Initiative (WHI) study prompted a reassessment of how hormone therapy data should be interpreted and applied.

The Menopause Society (formerly the North American Menopause Society, NAMS) now takes a clear position that hormone therapy remains the most effective treatment for vasomotor symptoms of menopause, and that for healthy women under 60 or within 10 years of menopause onset, the benefits of hormone therapy generally outweigh the risks. This “timing hypothesis” — sometimes called the “window of opportunity” — has been supported by multiple subsequent analyses and is reflected in current clinical guidance.

The Endocrine Society’s clinical practice guidelines on menopause hormone therapy similarly support individualized decision-making, emphasizing that risk-benefit assessment must account for a woman’s age, time since menopause, and personal health history. A blanket “avoid hormones” approach is not consistent with current evidence-based recommendations for appropriate candidates.

ACOG (the American College of Obstetricians and Gynecologists) has also updated its guidance to reflect a more nuanced understanding of hormone therapy, noting that women should receive accurate, evidence-based information to make informed decisions about their care — and that undertreatment of menopausal symptoms carries its own health risks, including effects on bone density, cardiovascular health, and quality of life.

Research into testosterone therapy for women — while less mature than the estrogen/progesterone literature — is accumulating. The Endocrine Society and the International Society for the Study of Women’s Sexual Health (ISSWSH) have published guidance acknowledging that testosterone, when used appropriately and in physiologic doses, may benefit some women with hypoactive sexual desire disorder and other symptoms of androgen insufficiency.

None of this means that hormone therapy is appropriate for every woman. Individual responses vary, and the decision to pursue any treatment requires a thorough evaluation and shared decision-making with a qualified physician. What the research does tell us is that the conversation should begin with comprehensive testing and honest, evidence-based guidance — not with dismissal or assumptions.

Myths vs. Facts About Women’s Hormone Testing

Myth: Your labs are “normal,” so nothing is wrong.
Fact: Reference ranges reflect statistical averages from population samples, not individual optima. A result within the reference range can still represent a hormonal environment that is suboptimal for a specific woman. When symptoms are present, they matter — and they warrant a clinical conversation that goes beyond whether a number falls within a broad reference band.

Myth: Hormone testing is only for women in menopause.
Fact: Hormonal imbalances can occur at any stage of adult life. Conditions such as polycystic ovary syndrome (PCOS), thyroid dysfunction, adrenal dysregulation, and low progesterone affect women across a wide age range. Perimenopause — the transitional phase before the final menstrual period — can begin in a woman’s late 30s or early 40s, often with significant symptoms that precede dramatic changes in lab values.

Myth: A single hormone test gives you the full picture.
Fact: Hormones interact in a dynamic system. Evaluating estrogen in isolation without progesterone, testosterone, thyroid, and cortisol leaves much of the picture unexamined. Additionally, a single point-in-time measurement may not capture the fluctuations that define a woman’s hormonal experience — particularly for premenopausal women whose levels change across the cycle.

Myth: Hormones are dangerous and best avoided.
Fact: This view was significantly influenced by an early interpretation of the Women’s Health Initiative study, which has since been substantially reanalyzed and contextualized. Current guidelines from the Menopause Society, Endocrine Society, and ACOG support individualized hormone therapy for appropriate candidates. Avoiding treatment also carries risks — including effects on bone health, cardiovascular function, and quality of life. The goal is informed, individualized decision-making, not categorical avoidance.

Myth: If you feel this way, it’s just stress or aging — there’s nothing to do.
Fact: Many of the symptoms women attribute to “just getting older” have a measurable physiologic basis that can be evaluated and, in many cases, meaningfully addressed. Fatigue, weight changes, sleep disruption, mood shifts, and cognitive changes deserve clinical investigation — not dismissal.

Myth: At-home hormone tests are just as reliable as clinical testing.
Fact: While at-home tests have improved in quality, they have significant limitations — particularly saliva-based testing, which measures only a fraction of circulating hormones and is subject to variability based on technique, hydration, and oral health. Comprehensive serum panels, interpreted by a physician who knows the patient’s history and symptoms, provide a much more reliable foundation for clinical decision-making.

LiteWell’s Clinical Approach

LiteWell was founded on a conviction that women — and all patients — deserve more than a rushed appointment and a standard blood panel. The practice model is designed around depth: enough time to understand a patient’s history, enough testing to see the full picture, and enough clinical expertise to connect the data to the individual.

Every patient relationship at LiteWell begins with a Free Medical Fit Call — a no-pressure, physician-guided conversation designed to understand whether LiteWell is the right fit. This is not a sales call. It is a clinical conversation where the physician learns about the patient’s history, current symptoms, and goals, and the patient learns what a LiteWell evaluation actually involves.

For women who choose to proceed, the Premier Discovery Intake is a comprehensive evaluation that goes beyond standard care. It includes a thorough health history, a review of prior labs and records, and an order for a comprehensive hormone panel tailored to the patient’s age, symptoms, and cycle status. The results are reviewed in detail with the patient — not just flagged as normal or abnormal, but explained in context.

LiteWell operates as a hybrid care model — combining the depth of an in-person evaluation at its Middleton location (serving Madison and the surrounding area) with the flexibility of telehealth for follow-up and ongoing management. This model is designed for women who value physician-level expertise and continuity of care, delivered in a way that fits their lives.

Treatment, when appropriate, is always individualized. No protocol is applied automatically. The right approach for one woman may be very different from the right approach for another — and that determination begins with the right tests, interpreted by a physician who is listening.

Related LiteWell Services

• HRT for Women
• Hormone Optimization
• Medical Weight Loss
• Longevity & Performance Medicine
• Free Medical Fit Call
• Premier Discovery Intake

Related Insights

• Perimenopause vs. Menopause: Understanding the Difference
• HRT for Women: Benefits, Risks, and Current Evidence
• Brain Fog: Causes, Evaluation, and Evidence-Based Strategies
• Low Energy and Fatigue: Finding the Root Cause
• Body Composition and Hormone Health

References

• The Menopause Society (formerly NAMS) — Hormone Therapy Position Statement
• Endocrine Society — Clinical Practice Guidelines: Menopause Hormone Therapy
• American College of Obstetricians and Gynecologists (ACOG) — Practice Bulletin: Management of Menopausal Symptoms
• U.S. Food and Drug Administration (FDA) — Menopause & Hormones
• National Institutes of Health (NIH) — National Institute on Aging: Menopause
• International Society for the Study of Women’s Sexual Health (ISSWSH) — Testosterone Therapy for Women

Medical Disclaimer

This article is intended for educational purposes only and should not be interpreted as personalized medical advice. Medical decisions should be made in consultation with a licensed healthcare professional who is familiar with your medical history. Treatment plans are individualized, and results vary. LiteWell does not provide emergency medical care.

Medication & Regulatory Disclosure

LiteWell’s hormone programs may include FDA-approved prescription therapies when clinically appropriate following medical evaluation. Compounded hormone products may be considered when a patient has a legitimate clinical need that cannot be met by an available FDA-approved product. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing consistency in the same manner as approved drugs. No treatment is prescribed automatically, and no specific outcome is guaranteed.